Advertisement

Topics

BRIEF—Tardive dyskinesia drug named CLSA’s outstanding therapeutic

09:31 EST 10 Nov 2017 | thePharmaLetter

Ingrezza (valbenazine) capsules, the first product approved for adults with tardive dyskinesia (TD),…

Original Article: BRIEF—Tardive dyskinesia drug named CLSA’s outstanding therapeutic

NEXT ARTICLE

More From BioPortfolio on "BRIEF—Tardive dyskinesia drug named CLSA’s outstanding therapeutic"

Advertisement
Quick Search
Advertisement
Advertisement